ORGANIZATION

Plaintiffs of HPV Vaccine Suits Urge LDP Group to Hear Stories of Sufferers

April 16, 2021
Plaintiffs of lawsuits over post-HPV-vaccination symptoms submitted a request on April 15 to urge a group of Liberal Democratic Party (LDP) lawmakers pushing for such vaccines to hear first-hand stories from women suffering from what they see as vaccine adverse…

To read the full story

Related Article

ORGANIZATION

By Yoshinori Sagehashi

The government is in the process of finalizing the 2021 Basic Policy for Economic and Fiscal Management and Reform (honebuto). This year’s policy will have a higher importance than previous ones because the drastic reforms of the drug pricing system…

By Eric Persoff

Last month, when discussing how life science manufacturers should react to the evolving pricing environment in Japan, I wrote about how manufacturers should align with stakeholders in government and the medical community on fair compensation for innovative, value creating, biopharmaceutical…

The average ratio of female employees at managerial posts stood at just 12.5% at pharmaceutical companies operating in Japan, a Jiho survey revealed. While foreign drug makers had an average 25.0%, the ratio came to as low as 9.8% for…

By Yoshinori Sagehashi

Biogen’s controversial Alzheimer’s drug aducanumab was filed for Japanese regulatory approval in December. If approved, it will be the first…

Japan’s key reimbursement policy panel on December 20 approved an outline of its FY2020 drug pricing reform next April, with…

Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…